{"organizations": [], "uuid": "d253e09184596001e33b0d84c7b1ebbba2e0eaba", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-siga-technologies-announces-fda-ac/brief-siga-technologies-announces-fda-accepts-nda-and-grants-priority-review-for-oral-tpoxx-to-treat-smallpox-idUSASB0C4FZ", "country": "US", "domain_rank": 408, "title": "BRIEF-SIGA Technologies Announces FDA Accepts NDA And Grants Priority Review For Oral TPOXX To Treat Smallpox", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-07T14:37:00.000+02:00", "replies_count": 0, "uuid": "d253e09184596001e33b0d84c7b1ebbba2e0eaba"}, "author": "", "url": "https://www.reuters.com/article/brief-siga-technologies-announces-fda-ac/brief-siga-technologies-announces-fda-accepts-nda-and-grants-priority-review-for-oral-tpoxx-to-treat-smallpox-idUSASB0C4FZ", "ord_in_thread": 0, "title": "BRIEF-SIGA Technologies Announces FDA Accepts NDA And Grants Priority Review For Oral TPOXX To Treat Smallpox", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "nda", "sentiment": "negative"}, {"name": "siga technologies inc", "sentiment": "none"}, {"name": "treat smallpox reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 39 PM / in 10 minutes BRIEF-SIGA Technologies Announces FDA Accepts NDA And Grants Priority Review For Oral TPOXX To Treat Smallpox Reuters Staff 1 Min Read \nFeb 7 (Reuters) - SIGA Technologies Inc: \n* SIGA TECHNOLOGIES ANNOUNCES FDA ACCEPTS NDA AND GRANTS PRIORITY REVIEW FOR ORAL TPOXX TO TREAT SMALLPOX Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-07T14:37:00.000+02:00", "crawled": "2018-02-07T14:52:55.003+02:00", "highlightTitle": ""}